TOMDF (Todos Medical) LT-Debt-to-Total-Asset: 2.11 (As of Sep. 2022)


What is Todos Medical LT-Debt-to-Total-Asset?

Todos Medical TOMDF -90.00% LT-Debt-to-Total-Asset is 2.11 as of Sep. 2022.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Todos Medical's long-term debt to total assests ratio for the quarter that ended in Sep. 2022 was 2.11.

Todos Medical's long-term debt to total assets ratio increased from Sep. 2021 (1.11) to Sep. 2022 (2.11). It may suggest that Todos Medical is progressively becoming more dependent on debt to grow their business.

Todos Medical  (OTCPK:TOMDF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Todos Medical LT-Debt-to-Total-Asset Related Terms

Todos Medical LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Todos Medical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Todos Medical LT-Debt-to-Total-Asset Chart

Todos Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.81 0.00 41.07 1.41 1.97

Todos Medical Quarterly Data
Dec15 Dec16 Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 1.97 0.00 2.21 2.11

Todos Medical LT-Debt-to-Total-Asset Calculation

Todos Medical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (A: Dec. 2021 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2021 )/Total Assets (A: Dec. 2021 )
=29.729/15.115
=1.97

Todos Medical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2022 is calculated as

LT Debt to Total Assets (Q: Sep. 2022 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2022 )/Total Assets (Q: Sep. 2022 )
=30.015/14.227
=2.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 2.11 mean?
Todos Medical (TOMDF) has a LT-Debt-to-Total-Asset of 2.11 as of Sep. 2022. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Todos Medical and its competitors.
Is Todos Medical's LT-Debt-to-Total-Asset too high?
Todos Medical's current LT-Debt-to-Total-Asset is 2.11.
How does Todos Medical's LT-Debt-to-Total-Asset compare to NDRA and IDXG?
Todos Medical's LT-Debt-to-Total-Asset of 2.11 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Diagnostics & Research company?
A good LT-Debt-to-Total-Asset depends on the Medical Diagnostics & Research industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Todos Medical and its competitors. Todos Medical's current LT-Debt-to-Total-Asset is 2.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Todos Medical stock overvalued right now?
Todos Medical (TOMDF) has a current LT-Debt-to-Total-Asset of 2.11. The current LT-Debt-to-Total-Asset is 2.11. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Todos Medical (TOMDF), the current LT-Debt-to-Total-Asset is 2.11 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Todos Medical Business Description

Address 121 Derech Menachem Begin, 30th Floor, Tel Aviv, ISR, 6701203
Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.